Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F-Sodium Fluoride (18F-NaF) PET-CT Imaging to Identify Vulnerable Plaques in Patients With Diabetes

NCT03530176 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT03530176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03530176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F-Sodium Fluoride (18F-NaF) PET-CT Imaging to Identify Vulnerable Plaques in Patients With Diabetes
Lead sponsor
University of Alberta
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2015
Completion date
October 15, 2017
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, complications of diabetes mellitus